NR6A1 and lung carcinoma: The above data indicate that miR-302a inhibits glucose metabolism, mitochondrial function and cell proliferation and that the miR-302a/HK1 axis may contribute to the effect of NR6A1 on reprogramming glycolysis in lung cancer cells.